CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 281 enrolled
Drug / intervention
Solyx Single Incision Sling System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01784588
NCT01784588N/ACompleted

A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence

Boston Scientific Corporation·interventional·Posted Feb 6, 2013·Updated Feb 10, 2021

In Brief

A clinical study evaluating Solyx Single Incision Sling System and Obtryx II Sling System for Stress Urinary Incontinence. Completed, enrolled 281 participants across 23 sites in 2 countries.

Detailed Summary

The purpose of this research study is to compare the treatment device (Solyx) to a different mesh sling or control device (Obtryx II) for the treatment of symptoms for Stress Urinary Incontinence (SUI). Safety information and patient outcomes will be collected for three (3) years and evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2013
Enrollment StartJun 1, 2013
Primary CompletionJan 17, 2018
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 13.4 years ago

Interventions

Solyx Single Incision Sling Systemdevice

Solyx Single Incision Sling System

Obtryx II Sling Systemdevice

Standard outside-in transobturator sling